Company Filing History:

6 out of 212

Cetus Corporation

patents

Cetus Oncology Corporation

patents

Years Active: 1989-1998

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5830452 - Method for enhancing the anti-tumor therapeutic index of interleukin-2 (1998-11-03),

2. 5725850 - Use of CSF-1 to treat tumor burden (1998-03-10),

3. 5702697 - Treatment for biological damage using a colony stimulating factor and a (1997-12-30),

4. 5667776 - Treatment for biological damage using tumor necrosis factor and a (1997-09-16),

5. 5508031 - Method for treating biological damage using a free-radial scavenger and (1996-04-16),

6. 5425940 - Combination therapy using interleukin-2 and tumor necrosis factor (1995-06-20),

7. 5104650 - Uses of recombinant colony stimulating factor-1 (1992-04-14),

8. 5098702 - Combination therapy using interleukin-2 and tumor necrosis factor (1992-03-24),

9. 4985241 - Therapeutic combination of free-radical scavenger and tumor necrosis (1991-01-15),

10. 4894225 - Combination therapy using antitumor immunotoxins with tumor necrosis (1990-01-16),

11. 4863727 - Combination therapy using interleukin-2 and tumor necrosis factor (1989-09-05),

12. 4863726 - Combination therapy using immunotoxins with interleukin-2 (1989-09-05),

Title: The Innovative Contributions of Robert Zimmerman

Introduction

Robert Zimmerman is a notable inventor based in Lafayette, CA, with a remarkable portfolio of 12 patents. His work primarily focuses on advancements in medical therapies, particularly in the treatment of tumors. Zimmerman's innovative methods have the potential to significantly enhance therapeutic outcomes for patients.

Latest Patents

Among his latest patents is a method for enhancing the anti-tumor therapeutic index of interleukin-2. This invention relates to a technique for administering IL-2 to tumor patients, aiming to maximize therapeutic efficacy while minimizing toxicity. Another significant patent involves the use of CSF-1 to treat tumor burden. CSF-1 is a lymphokine that plays a crucial role in treating or preventing various infections and conditions, including neoplasms and immunosuppression induced by chemotherapy. This protein can be obtained in usable amounts through recombinant methods, including the cloning and expression of murine and human DNA sequences.

Career Highlights

Robert Zimmerman has had a distinguished career, working with prominent companies such as Cetus Corporation and Chiron Corporation. His contributions to these organizations have been instrumental in advancing medical research and therapeutic techniques.

Collaborations

Throughout his career, Zimmerman has collaborated with notable colleagues, including Jeffrey L Winkelhake and Benedict J Marafino, Jr. These partnerships have fostered innovation and have led to significant advancements in their respective fields.

Conclusion

Robert Zimmerman's contributions to medical innovation through his patents and collaborations highlight his commitment to improving patient outcomes. His work continues to influence the landscape of tumor treatment and therapeutic methodologies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.